About 2 Trademarks found for “YENRILA”

Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used in tissue and organ transplantation; pharmaceutical preparations for use in opthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; anti-infectives; antivirals; anti-biotics; systemic and topical anti-fungals; anti-bacterials

Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases including metabolic disorders and diabetes; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in gastroenterology; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; in vitro diagnostic agents for medical use; smoking cessation preparations, namely patches, pills, capsules and gums for the delivery of smoking cessation medication; preparations for the repair of trauma or damage to the tissue or skin; anti-cholesterol preparations, namely medication for lowering cholesterol; hormonal preparations, namely hormone replacement medication.